Search clinical trials for: Herpes Zoster Vaccine GSK1437173A

Total 190 results

McMaster University
Merck Sharp & Dohme LLC

Completed

Zoster Vaccine Response in the Frail Elderly

Immune System Diseases

Canada
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

Prevention of : Herpes-Zoster
CanSino Biologics Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years

Herpes Zoster

Canada
University of California, San Francisco

Active, not recruiting

The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19) (BOOSTED)

COVID-19 | Vaccine Reaction | COVID-19 Pandemic

United States
Universidad del Desarrollo
Pontificia Universidad Catolica de Chile; University of Chile; Ministry of Health...

Active, not recruiting

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster (REFUERZO)

Covid19

Chile
Laval University

Completed

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Human Papillomavirus

Canada
Tulane University

Completed

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Fibrosis | Herpes Zoster
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

Herpes Zoster

United States
Merck Sharp & Dohme LLC
Kaiser Permanente

Completed

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

Herpes Zoster | Shingles
Merck Sharp & Dohme LLC

Completed

Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)

Healthy
University of Oklahoma
Oklahoma Medical Research Foundation

Completed

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents (NH-Shingrix)

Herpes Zoster | Corona Virus Infection | Allergy and Immunology

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

Herpes Zoster
GlaxoSmithKline

Completed

Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Herpes Simplex

United States, Australia, Spain, Romania, United Kingdom, Belgium, Canada, Estonia, France, Hungary, New Zealand, Sweden, Netherlands, Norway, Greece, Denmark, Iceland, Lithuania
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

Herpes Zoster
Wuerzburg University Hospital

Recruiting

The Influence of Trained Immunity in COVID-19 Vaccinated Individuals

Vaccination; Infection | Zoster Varicella

Germany
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Hepatitis C

United States
University of Washington
Merck Sharp & Dohme LLC

Completed

Immune Response to Shingles Vaccination

Shingles

United States
Ann & Robert H Lurie Children's Hospital of Chicago
Children's Hospital Colorado; Children's Hospital Medical Center, Cincinnati

Not yet recruiting

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Varicella Zoster

United States
US Department of Veterans Affairs
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp...

Completed

Shingles Prevention Study (SPS)

Herpes Zoster | Postherpetic Neuralgia

United States
Louis Stokes VA Medical Center
Duke University

Unknown

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Shingles
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

COVID-19

United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Herpes Zoster
University of Arizona

Completed

A Behavioral Intervention With Foster Families

Family Relationship | Behavior, Social | Sibling Relations

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster

United States, Germany, Estonia, Canada
Duke University
Washington University School of Medicine; University of Pittsburgh; Centers for... and other collaborators

Completed

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

COVID-19 | Influenza

United States
Frank Lieberman
Oncovir, Inc.

Completed

Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

Malignant Glioma

United States
GlaxoSmithKline

Completed

Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults

Herpes Simplex
Central Adelaide Local Health Network Incorporated
National Health and Medical Research Council, Australia; University of Adelaide and other collaborators

Not yet recruiting

Safety and Immunogenicity of Recombinant Zoster Vaccine for Kidney Transplant Recipients (SIR ZOSTER)

Immunosuppression | Vaccine Response Impaired
University of Wisconsin, Madison
GlaxoSmithKline

Not yet recruiting

Study of Response to Zoster Vaccine in Adults With Inflammatory Bowel Disease Treated With Medications

Inflammatory Bowel Diseases | IBD

United States
Prof Patrice Lalive

Recruiting

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients (MSHINGVAX)

Zoster | Shingles

Switzerland
Calmy Alexandra

Recruiting

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls (Shingr'HIV)

RZV Vaccine (Shingrix ®)

Switzerland, France
Oklahoma Medical Research Foundation

Completed

Safety of Zostavax Vaccination in Rheumatoid Arthritis

Rheumatoid Arthritis | Varicella Zoster

United States
GlaxoSmithKline

Completed

Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

Prophylaxis Herpes Simplex

Belgium
Emory University

Terminated

Solid Organ Transplant SHINGRIX

Kidney Transplant; Complications

United States
Danish Headache Center

Completed

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

Post-Traumatic Headache

Denmark
University of Colorado, Denver
GlaxoSmithKline

Recruiting

Shingrix In Recipients of Allogeneic Transplants (Allo)

Stem Cell Transplant | Bone Marrow Transplant

United States
Changchun BCHT Biotechnology Co.

Completed

Study on Efficacy of Attenuated Zoster Vaccine, Live

Herpes Zoster

China
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)

Herpes Zoster
Shanghai Institute Of Biological Products

Completed

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Herpes Zoster

China
GlaxoSmithKline

Completed

Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease

Herpes Simplex
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Herpes Zoster | Shingles
Merck Sharp & Dohme LLC
University of Colorado, Denver; Duke University

Completed

Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)

Herpes Zoster | Varicella-zoster Vaccine
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)

Herpes Zoster
Jiangsu Rec-Biotechnology Co., Ltd.

Completed

The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)

Herpes Zoster

Philippines
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

Herpes Zoster | Shingles
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX(R) Local Registration Trial (V211-019)

Varicella Virus Infection
University of Wisconsin, Madison
Boston Medical Center

Active, not recruiting

Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Herpes Zoster

United States
Mansoura University

Completed

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Bladder Cancer | Oncology | Incontinence | Incontinence, Daytime Urinary | Incontinence, Nighttime Urinary | Orthotopic Neobladder

Egypt

3

Subscribe